Total Payments
$15,206
2024 Payments
$550.29
Companies
9
Transactions
46
Medicare Patients
548
Medicare Billing
$56,699
Payment Breakdown by Category
Consulting$11,970 (78.7%)
Food & Beverage$1,772 (11.7%)
Travel$1,433 (9.4%)
Education$30.42 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,970 | 3 | 78.7% |
| Food and Beverage | $1,772 | 35 | 11.7% |
| Travel and Lodging | $1,433 | 6 | 9.4% |
| Education | $30.42 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $11,232 | 21 | $0 (2019) |
| Janssen Biotech, Inc. | $3,055 | 10 | $0 (2018) |
| ABBVIE INC. | $501.49 | 8 | $0 (2024) |
| Smith+Nephew, Inc. | $129.79 | 1 | $0 (2022) |
| ACUMED LLC | $117.40 | 1 | $0 (2024) |
| Celgene Corporation | $96.63 | 1 | $0 (2022) |
| PFIZER INC. | $34.97 | 2 | $0 (2023) |
| Skeletal Dynamics Inc | $23.81 | 1 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $14.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $550.29 | 7 | ABBVIE INC. ($409.08) |
| 2023 | $19.05 | 1 | PFIZER INC. ($19.05) |
| 2022 | $242.34 | 3 | Smith+Nephew, Inc. ($129.79) |
| 2020 | $12.35 | 1 | AbbVie Inc. ($12.35) |
| 2019 | $11,042 | 16 | Takeda Pharmaceuticals U.S.A., Inc. ($11,022) |
| 2018 | $1,586 | 11 | Janssen Biotech, Inc. ($1,301) |
| 2017 | $1,753 | 7 | Janssen Biotech, Inc. ($1,753) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $119.59 | General |
| 09/20/2024 | ACUMED LLC | ACUMED (Device), InFrame Implant | Food and Beverage | In-kind items and services | $117.40 | General |
| Category: Screw & Pin | ||||||
| 06/05/2024 | Skeletal Dynamics Inc | Geminus (Device), Align, IJS | Food and Beverage | Cash or cash equivalent | $23.81 | General |
| Category: Orthopedic | ||||||
| 03/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $120.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $89.13 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/20/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/22/2022 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $96.63 | General |
| 04/15/2022 | PFIZER INC. | XELJANZ (Drug) | Education | In-kind items and services | $15.92 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/26/2022 | Smith+Nephew, Inc. | Ascension (Device), EVOS, VLP MINI-MOD | Food and Beverage | In-kind items and services | $129.79 | General |
| Category: Extremity, Upper | ||||||
| 12/04/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Consulting Fee | Cash or cash equivalent | $9,800.00 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Travel and Lodging | In-kind items and services | $192.66 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Travel and Lodging | In-kind items and services | $155.83 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $76.86 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $72.81 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $65.52 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Travel and Lodging | Cash or cash equivalent | $49.00 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | Cash or cash equivalent | $30.78 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: Lower GI | ||||||
| 07/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Lower GI | ||||||
| 06/27/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Travel and Lodging | In-kind items and services | $385.81 | General |
| Category: Lower GI | ||||||
| 05/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $58.30 | General |
| 05/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $58.30 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 78 | 78 | $111,518 | $9,537 |
| 2022 | 3 | 100 | 100 | $131,840 | $10,302 |
| 2021 | 5 | 221 | 229 | $249,198 | $22,549 |
| 2020 | 6 | 149 | 157 | $146,812 | $14,310 |
Total Patients
548
Total Services
564
Medicare Billing
$56,699
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 31 | 31 | $57,846 | $6,575 | 11.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $40,068 | $1,965 | 4.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $13,604 | $997.35 | 7.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 30 | $55,980 | $5,257 | 9.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $24,344 | $2,965 | 12.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 36 | 36 | $51,516 | $2,080 | 4.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 50 | 52 | $97,032 | $10,828 | 11.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 59 | 59 | $42,244 | $4,496 | 10.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 65 | 66 | $94,446 | $4,044 | 4.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 31 | 31 | $12,268 | $2,528 | 20.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 16 | 21 | $3,208 | $652.89 | 20.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 29 | 29 | $54,114 | $6,150 | 11.4% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 39 | 39 | $55,809 | $2,969 | 5.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 30 | 32 | $22,912 | $2,344 | 10.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 18 | 18 | $7,235 | $1,499 | 20.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 20 | 25 | $3,900 | $804.00 | 20.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 13 | 14 | $2,842 | $545.42 | 19.2% |
About Dr. Frank Scott, MD
Dr. Frank Scott, MD is a Internal Medicine healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1588822878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Scott, MD has received a total of $15,206 in payments from pharmaceutical and medical device companies, with $550.29 received in 2024. These payments were reported across 46 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($11,970).
As a Medicare-enrolled provider, Scott has provided services to 548 Medicare beneficiaries, totaling 564 services with total Medicare billing of $56,699. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology, Gastroenterology
- Location Aurora, CO
- Active Since 05/23/2008
- Last Updated 07/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588822878
Products in Payments
- Entyvio (Biological) $10,982
- STELARA (Biological) $3,055
- SKYRIZI (Biological) $289.49
- Ascension (Device) $129.79
- ACUMED (Device) $117.40
- Humira (Biological) $80.06
- XELJANZ (Drug) $34.97
- Geminus (Device) $23.81
- Kanuma (Drug) $14.50
- HUMIRA (Biological) $12.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aurora
Dr. Payal Kohli, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Wendy Tzou, M.d, M.D
Internal Medicine — Payments: $339,300
Internal Medicine $339,300
Miss. Sapna Patel, Md, MD
Internal Medicine — Payments: $188,415
Internal Medicine $188,415
Viralkumar Shah, Md, MD
Internal Medicine — Payments: $178,835
Internal Medicine $178,835
Dr. Elena Shagisultanova, Md, Phd, MD, PHD
Internal Medicine — Payments: $171,856
Internal Medicine $171,856
Lohit Garg, Md, MD
Internal Medicine — Payments: $121,577
Internal Medicine $121,577